Paragon 28, Inc.
General ticker "FNA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $766.4M (TTM average)
Paragon 28, Inc. follows the US Stock Market performance with the rate: 18.1%.
Estimated limits based on current volatility of 0.3%: low 13.02$, high 13.09$
Factors to consider:
- US accounted for 82.8% of revenue in the fiscal year ended 2024-12-31
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.23$, 14.07$]
- 2025-12-31 to 2026-12-31 estimated range: [6.03$, 13.78$]
Financial Metrics affecting the FNA estimates:
- Negative: Non-GAAP EPS, $ of -0.63 <= 0.04
- Negative: Operating cash flow per share per price, % of -3.10 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Industry operating cash flow per share per price (median), % of -3.23 <= 2.82
- Positive: 43.26 < Shareholder equity ratio, % of 44.92 <= 63.75
- Negative: 0.10 < Interest expense per share, $ of 0.14
- Positive: Industry inventory ratio change (median), % of -0.37 <= -0.28
- Positive: -0.87 < Investing cash flow per share, $ of -0.19
Short-term FNA quotes
Long-term FNA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $181.38MM | $216.39MM | $256.18MM |
| Operating Expenses | $243.09MM | $262.05MM | $296.96MM |
| Operating Income | $-61.71MM | $-45.66MM | $-40.78MM |
| Non-Operating Income | $-4.01MM | $-11.66MM | $-12.70MM |
| Interest Expense | $4.13MM | $5.17MM | $11.53MM |
| R&D Expense | $24.65MM | $30.08MM | $27.07MM |
| Income(Loss) | $-65.71MM | $-57.32MM | $-53.48MM |
| Taxes | $-0.06MM | $0.21MM | $1.16MM |
| Profit(Loss)* | $-67.33MM | $-57.53MM | $-54.64MM |
| Stockholders Equity | $142.60MM | $169.72MM | $130.59MM |
| Inventory | $60.95MM | $98.06MM | $90.03MM |
| Assets | $255.79MM | $332.68MM | $290.72MM |
| Operating Cash Flow | $-49.18MM | $-63.89MM | $-27.15MM |
| Capital expenditure | $43.09MM | $28.03MM | $16.95MM |
| Investing Cash Flow | $-60.69MM | $-26.99MM | $-15.69MM |
| Financing Cash Flow | $39.49MM | $128.65MM | $0.29MM |
| Earnings Per Share** | $-0.88 | $-0.70 | $-0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.